Vetsys Pharmaceutical
Vetsys Pharmaceutical
Featured GMP-certified sustained-release boluses and active pharmaceutical formulations engineered for high bioavailability and controlled ruminal degradation across Serbian cattle and swine sectors.
Understanding regional livestock dynamics, climate shifts, and regulatory compliance under the Serbian Ministry of Agriculture, Forestry and Water Management (MPŠV).
The city region of Belgrade, situated at the confluence of the Sava and Danube rivers, forms the logistical core connecting the fertile agricultural plain of Vojvodina with the intensive livestock zones of Šumadija and Mačva. With over 1.2 million head of cattle and significant dairy herds operating across the Belgrade District, farm operators face pressing challenges related to labor overhead, sub-clinical mastitis, and endoparasite pressure. High humidity in river valleys amplifies gastrointestinal nematode proliferation, demanding long-acting therapeutic interventions that eliminate frequent dosing routines.
As Serbia aligns its legal frameworks with European Union standards—specifically EU Regulation 2019/6 on Veterinary Medicinal Products—distributors in Belgrade must source pharmaceutical formulations certified under strict Good Manufacturing Practices (GMP). The Medicines and Medical Devices Agency of Serbia (ALIMS) mandates rigorous bioequivalence, dissolution stability, and residue depletion validation. Chinese B2B suppliers offering high-density sustained-release boluses backed by thorough CTD dossiers deliver a decisive competitive edge to Serbian importers navigating these stringent quality benchmarks.
How density-weighted matrices and erodible polymers provide zero-order therapeutic release profiles over extended period intervals.
To prevent premature regurgitation or pass-through into the omasum, high-performance sustained-release boluses maintain a specific gravity exceeding 2.0 g/cm³ (typically 2.2–2.8 g/cm³). Utilizing inert iron weight cores or dense mineral fillers, the bolus lodges securely within the reticulum or the reticulo-ruminal fold of cattle, serving as a long-term therapeutic reservoir unaffected by gastrointestinal motility.
Our formulation architecture integrates hydrophobic and hydrophilic wax polymers (such as carnauba wax, ethylcellulose, and hydroxypropyl methylcellulose). As ruminal fluid permeates the outer matrix layer, controlled surface erosion occurs at a uniform rate. This process yields constant zero-order release kinetics, ensuring therapeutic plasma concentrations of active ingredients (like Oxytetracycline or Fenbendazole) for up to 90 to 180 days.
Protective lipid and polymer shells shield bio-active molecules—such as Tiamulin Fumarate and Amoxicillin—from enzymatic hydrolytic breakdown by rumen microflora. The targeted micro-encapsulation allows sustained systemic absorption across the intestinal mucosa without disturbing essential rumen microbial fermentation dynamics.
Established in 2005, Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys) is a leading manufacturer in the animal pharmaceutical industry with a registered capital of 30 million RMB. The facility includes specialized workshops for producing a wide range of products, including powders & premixes, injections, powder injections, oral solutions, tablets, granules, herbal drug extracts, and disinfectants.
Vetsys operates in compliance with strict Good Manufacturing Practices (GMP) to ensure that all products meet the highest quality standards. Over the years, the company has grown to become one of the top animal pharmaceutical producers in China, achieving annual sales of over USD 20 million in the domestic market by 2015.
Technological Innovation and Research: Vetsys distinguishes itself from competitors by placing a strong emphasis on technological development and continuous innovation. We have established an independent research institute equipped with five specialized laboratories and a team of world-class scientists. This enables us to quickly adapt to market demands and produce cutting-edge solutions for animal health. Our commitment to research ensures that Vetsys remains at the forefront of the industry, continuously enhancing our product offerings and contributing to advancements in animal healthcare.
Quality Management: Quality is the cornerstone of our operations, and Vetsys has developed a comprehensive quality management system to oversee every aspect of production. We adhere to rigorous GMP standards, ensuring that all products are manufactured under optimal conditions and undergo extensive quality control checks before reaching the market.
Vetsys believes that excellence in product quality is essential to long-term growth and sustainability, both for the company and the animal health industry as a whole. Our focus on quality management allows us to maintain trust and loyalty among our customers, setting us apart as a reliable partner in animal healthcare.
Commitment to Sustainability and Global Expansion: As part of our long-term vision, Vetsys is also committed to sustainability. We continue to invest in green technologies and environmentally friendly practices to minimize the impact of our operations on the environment. Our products are not only designed for efficacy but also to promote the overall well-being of both animals and the environment.
In addition to our strong presence in the domestic market, Vetsys is actively exploring international expansion, aiming to bring high-quality, innovative animal health solutions to global markets, specifically tailored for key livestock regions like the Belgrade and wider Serbian market. Our future strategy includes partnerships, research collaborations, and expanding our manufacturing capabilities to meet the increasing demand for safe and effective animal drugs worldwide.
Empowering Serbian veterinarians and commercial farm managers with target therapeutic protocols engineered for regional disease profiles.
Location: Suburban Belgrade & Pančevo Dairy Belt
Challenge: High risk of uterine infection, acute metritis, and systemic fever post-calving during humid summer months.
Solution: Administration of Sustained Release Long Acting Oxytetracycline Boluses upon calving ensures steady plasma antimicrobial pressure for 7–10 days without daily labor-intensive injections, accelerating uterine involution and preserving milk yield integrity.
Location: Pasture Operations in Šumadija & Kolubara
Challenge: Re-infection cycles of Ostertagia ostertagi and Dictyocaulus viviparus during spring turnout and autumn housing.
Solution: Single oral administration of Fenbendazole Sustained-Release Boluses provides constant low-dose systemic anthelmintic release over 90 days, eradicating both adult and migrating larval nematodes while stopping pasture egg shedding completely.
Location: Commercial Swine Operations in Mačva Region
Challenge: Enzootic pneumonia caused by Mycoplasma hyopneumoniae aggravated by seasonal temperature drops.
Solution: Strategic blending of Tiamulin Hydrogen Fumarate 80% Soluble Granules/Premix into feed/water lines creates persistent tissue concentration in lung parenchyma, arresting swine dysentery and respiratory outbreaks efficiently.
Efficient supply chain management is crucial for pharmaceutical integrity. Vetsys coordinates seamless multimodal freight protocols from our state-of-the-art manufacturing hub in Zhengzhou directly to major Serbian customs clearance terminals.
Secure factory-direct pricing, customized formulation development, and exclusive regional distribution rights with Zhengzhou Vetsys Pharmaceutical Co., Ltd.
Explore our complete GMP-certified range of antiparasitic boluses, premixes, and water-soluble powders engineered for maximal field efficacy.
State-of-the-art machinery and precision automation guaranteeing strict GMP quality standards from raw material compounding to final packaging.
In-depth technical and regulatory clarity for veterinary drug importers, wholesalers, and commercial livestock integration companies.
Our sustained-release boluses are engineered with heavy density cores (typically iron powder or dense mineral matrices) attaining a specific density above 2.0 g/cm³ (up to 2.8 g/cm³). This specific gravity ensures that upon oral administration via a bolus gun, the bolus settles immediately into the floor of the reticulum or reticulo-ruminal fold. Its mass prevents it from being carried upward by ruminal contraction waves during rumination, keeping it fixed for its entire dissolution lifecycle of 90 to 180 days.
Zhengzhou Vetsys Pharmaceutical Co., Ltd. provides comprehensive regulatory support packages aligned with CTD formats required by the Medicines and Medical Devices Agency of Serbia (ALIMS). This includes complete Certificates of Analysis (COA), validated HPLC stability assay data (Zone IVb), Good Manufacturing Practice (GMP) certificates, ISO certifications, active substance master files (ASMF), and residue depletion study data for withdrawal period establishment.
Standard sea-to-rail intermodal transit from China to Belgrade Customs Terminals generally ranges between 28 and 35 days depending on port selection (Rijeka, Bar, or Thessaloniki). For high-priority orders or urgent disease outbreak interventions, air freight solutions via Belgrade Nikola Tesla Airport (BEG) can deliver orders within 5 to 7 days from batch clearance.
Yes. Leveraging our 5 independent specialized laboratories and advanced injection, extrusion, and tablet press workshops, Vetsys offers OEM/ODM custom formulation services. We can tailor active pharmaceutical ingredient concentrations (e.g., Fenbendazole + Trace Mineral complexes or Oxytetracycline + NSAID matrices), adjust dissolution erosion profiles, and stamp custom branding/logos directly onto the bolus surface.
Contact our international export division today to receive complete technical dossiers, product samples, and direct B2B manufacturer pricing.
Send Inquiry Now
